LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (Q2)Jun 30, 2018 | (Q1)Mar 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 85.56%1.71B | 33.28%919.25M | -357.62%-44.52M | -38.40%689.69M | 17.28M | -13.82%1.12B | -1.94%1.3B | 2.96%1.32B | 15.84%481.72M | 21.34%282.56M |
Net income from continuing operations | 21.62%164.62M | 107.57%135.35M | 126.89%28.14M | -43.23%65.21M | ---104.65M | -78.52%114.85M | -37.90%534.64M | 61.62%860.91M | 84.92%241.25M | 75.60%196.75M |
Operating gains losses | -58.98%15.27M | -92.23%37.23M | -80.04%99.36M | 756.28%479.13M | --497.69M | 176.07%55.95M | -565.33%-73.56M | 83.87%15.81M | -366.20%-2.1M | 554.77%1.45M |
Depreciation and amortization | -21.89%1.75M | -41.28%2.24M | -38.95%443.72K | -36.80%3.82M | --726.78K | -44.61%6.05M | -17.91%10.92M | 23.09%13.3M | 24.79%3.26M | 33.89%2.99M |
Deferred tax | 87.68%-16.49M | 29.52%-133.91M | 35.22%-47.86M | -101.30%-190.01M | ---73.89M | -2,514.77%-94.39M | 103.72%3.91M | -81.53%-105.09M | 40.24%-18.02M | -221.78%-35.94M |
Other non cashItems | 31.98%1.27B | 74.42%964.56M | 1,209.02%33.87M | 13.87%553M | --2.59M | 241.52%485.65M | -1,354.21%-343.17M | --27.36M | ---- | ---- |
Change in working capital | 123.31%77.04M | -656.74%-330.44M | -1,748.49%-243.63M | -85.60%59.35M | --14.78M | -47.69%412.09M | 1,918.58%787.75M | -87.12%39.03M | -14.58%166.31M | -186.14%-36.16M |
-Change in other current assets | 109.05%15.13M | -441.51%-167.19M | -249.27%-89.05M | -8.54%-30.88M | --59.66M | -129.22%-28.45M | 170.27%97.35M | 52.11%-138.55M | -2,252.25%-32.03M | -255.18%-19.84M |
-Change in other current liabilities | 3,613.41%221.93M | -103.04%-6.32M | -17.33%24.07M | -50.65%207.81M | --29.11M | -34.79%421.08M | 214.26%645.69M | -70.27%205.47M | -6.49%199.09M | -97.39%1.6M |
-Change in other working capital | -1.97%-160.02M | -33.46%-156.93M | -141.43%-178.64M | -704.19%-117.58M | ---73.99M | -56.47%19.46M | 260.27%44.7M | 71.75%-27.89M | 96.15%-759.01K | 44.16%-17.92M |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | 85.56%1.71B | 33.28%919.25M | -357.62%-44.52M | -38.40%689.69M | --17.28M | -13.82%1.12B | -1.94%1.3B | 2.96%1.32B | 15.84%481.72M | 21.34%282.56M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -126.18%-2.48B | 53.28%-1.1B | -77.60%181.67M | -548.54%-2.35B | 810.97M | -89.38%524.05M | 660.32%4.94B | 106.77%649.26M | 62.10%-1.09B | 115.27%252.63M |
Net investment purchase and sale | -73.49%108.63M | 177.36%409.84M | -39.96%293.15M | -324.48%-529.81M | --488.25M | 639.87%236.02M | 109.97%31.9M | 6.93%-319.95M | 100.50%504.99K | 666.00%280.76M |
Net proceeds payment for loan | -68.75%-2.48B | 19.20%-1.47B | -122.59%-73.19M | -728.69%-1.82B | --323.94M | -94.11%289.09M | 415.92%4.91B | 110.24%951.33M | 61.67%-1.06B | 96.53%-55.62M |
Net PPE purchase and sale | -27.79%-114.46M | -2,651.68%-89.57M | -7,153.45%-88.29M | -206.49%-3.26M | ---1.22M | 70.16%-1.06M | 69.78%-3.56M | 37.60%-11.78M | 24.15%-4.4M | 45.55%-2.16M |
Net business purchase and sale | --0 | --50M | ---- | --0 | ---- | --0 | ---- | -48.61%29.66M | ---- | --29.66M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -126.18%-2.48B | 53.28%-1.1B | -77.60%181.67M | -548.54%-2.35B | --810.97M | -89.38%524.05M | 660.32%4.94B | 106.77%649.26M | 62.10%-1.09B | 115.27%252.63M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 448.96%1.01B | -114.91%-288.16M | 147.34%265.13M | 241.36%1.93B | -560.02M | 82.24%-1.37B | -301,819.75%-7.7B | -100.03%-2.55M | -22.37%1.61B | -113.51%-257.89M |
Net issuance payments of debt | 540.68%1.11B | -113.00%-251.27M | 141.77%233.92M | 241.36%1.93B | ---560.02M | 82.24%-1.37B | -2,332.82%-7.7B | -103.42%-316.33M | -22.37%1.61B | -113.51%-257.89M |
Net commonstock issuance | 64.98%-30.69M | ---87.63M | ---19.54M | --0 | --0 | --0 | ---- | --313.78M | ---- | ---- |
Net other financing activities | -240.09%-71.1M | --50.75M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 448.96%1.01B | -114.91%-288.16M | 147.34%265.13M | 241.36%1.93B | ---560.02M | 82.24%-1.37B | -301,819.75%-7.7B | -100.03%-2.55M | -22.37%1.61B | -113.51%-257.89M |
Net cash flow | ||||||||||
Beginning cash position | -20.58%1.77B | 13.80%2.23B | -30.08%1.37B | 14.99%1.96B | --1.96B | -46.06%1.71B | 165.61%3.16B | 410.58%1.19B | 103.75%1.47B | 410.58%1.19B |
Current changes in cash | 148.68%227.39M | -271.91%-467.1M | 49.97%402.27M | -1.73%271.71M | --268.24M | 118.94%276.49M | -174.06%-1.46B | 105.47%1.97B | 350.26%995.43M | -43.10%277.3M |
Effect of exchange rate changes | -74.12%2.03M | 757.46%7.85M | -254.40%-3.33M | 94.29%-1.19M | ---940.43K | -645.40%-20.92M | 2,009.36%3.84M | 91.17%-200.92K | 3.18%-689.07K | 8.68%-199.23K |
End cash position | 12.95%2B | -20.58%1.77B | -20.58%1.77B | 13.80%2.23B | --2.23B | 14.99%1.96B | -46.06%1.71B | 165.61%3.16B | 665.25%2.46B | 103.75%1.47B |
Free cash flow | 91.86%1.59B | 20.92%829.36M | -916.75%-132.9M | -38.56%685.89M | --16.27M | -13.77%1.12B | -1.17%1.29B | 3.40%1.31B | 16.39%477.2M | 22.49%280.35M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | -- | Unqualified Opinion with Explanatory Notes | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | -- | -- |